FDA closes out series of patient-focused drug development guidance
The FDA on Wednesday released its fourth (of four) patient-focused drug development guidance documents, with this latest draft featuring long-awaited advice on how to collect …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.